Malama Health, a Medicaid-first maternal health company, has raised $9.2M in seed funding led by Acumen America. The startup provides doula-led continuous care from pregnancy through the postpartum year, using an app for remote monitoring, care navigation, and social support referrals. The capital will scale operations nationwide, expanding the doula workforce and partnerships with Medicaid plans.
Medicaid Doula Coverage Accelerates
The raise aligns with over 30 states now reimbursing doula services through Medicaid, including Louisiana's rollout starting January 2026. Competitor Oula Health raised $28M Series B in 2024 to build hybrid maternity clinics. Malama Health differentiates with its doula-led model integrated with tech for high-risk Medicaid patients, addressing access gaps in underserved areas.
Maternal Disparities Drive Interventions
High-risk pregnancies among Medicaid-insured women face elevated preterm birth and NICU admission rates. Malama Health reports serving 45,000+ women across 50 states through its app, with partnerships at 600+ clinics and hospitals including Stanford and UCSF. Outcomes include 38-45% preterm birth reductions and 6-19% fewer NICU stays compared to benchmarks.
Doula-Tech Hybrid Reduces Risks
Malama Health employs community-based doulas for births and home visits, paired with an app tracking glucose, blood pressure, and weight via wearables. Providers access a HIPAA-compliant dashboard with EHR integration for real-time risk escalation. This contrasts clinic-heavy models like Oula Health by embedding doulas in communities for continuous support.
As CEO Mika Eddy told Fierce Healthcare:
"Women in this country are trying to navigate a sick care system that was never designed for them."
AI Powers Postpartum Prevention
The company secured a $2.4M NIH Fast Track SBIR grant for its AI-driven postpartum Type 2 diabetes prevention program, CDC-approved with lifestyle coaching. Internal data shows 80% glycemic control within two weeks and NPS of 86. This extends care beyond birth, targeting gestational diabetes complications.
Impact Investors Signal Equity Focus
Acumen America led with participation from Coyote Ventures, Wisdom Ventures, Capital F, Y Combinator, Alpine Investors, and Samsung Next. The round includes $2.3M from NIH and $1M state funding, blending mission-driven and growth capital. Investors back Malama Health's focus on health equity for Medicaid populations.
As Acumen America's Veenu Aulakh stated:
"Health equity in maternal care requires trust."
Femtech Market Scales to $97B
The femtech market stands at $39.29B in 2024, projected to reach $97.25B by 2030 at 16.37% CAGR. Malama Health leads the Medicaid doula niche amid trends in remote monitoring and state policy shifts. Competitors like Mother Goose Health focus on platform coordination without doula integration.
Founders Blend Tech and Clinical Expertise
Co-founder CEO Mika Eddy brings UnitedHealth Group clinical product innovation and Stanford GSB training. CTO Orlando Li scaled Airbnb's Experiences marketplace. Chief Clinical Director Priyanka Wali, a double-board-certified MD, oversaw digital mental health at Meru Health. This team combines platform engineering, payer experience, and clinical oversight for nationwide scaling.
Nationwide Doula Network Expansion
Malama Health plans to grow its doula workforce and enter more Medicaid markets, building on Colorado expansion and 50-state app reach. With 43,000+ app users and 400+ in-person care patients, the funding supports 10x growth in supported mothers.